Menu Search
Equities

Molina Healthcare Inc

MOH:NYQ

Molina Healthcare Inc

Actions
Health CareHealth Care Providers
  • Price (USD)318.91
  • Today's Change-9.68 / -2.95%
  • Shares traded653.21k
  • 1 Year change-10.94%
  • Beta0.5651
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Molina Healthcare Inc grew revenues 6.56% from 31.97bn to 34.07bn while net income improved 37.75% from 792.00m to 1.09bn.
Gross margin16.12%
Net profit margin2.92%
Operating margin4.19%
Return on assets7.47%
Return on equity26.45%
Return on investment16.58%
More ▼

Cash flow in USDView more

In 2023, Molina Healthcare Inc increased its cash reserves by 21.25%, or 860.00m. The company earned 1.66bn from its operations for a Cash Flow Margin of 4.88%. In addition the company used 744.00m on investing activities and also paid 58.00m in financing cash flows.
Cash flow per share22.82
Price/Cash flow per share14.19
Book value per share83.68
Tangible book value per share49.95
More ▼

Balance sheet in USDView more

Molina Healthcare Inc has a Debt to Total Capital ratio of 34.65%, a lower figure than the previous year's 61.30%.
Current ratio1.55
Quick ratio--
Total debt/total equity0.5302
Total debt/total capital0.3465
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 38.70%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
EPS growth(5 years)12.22
EPS (TTM) vs
TTM 1 year ago		22.79
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.